Medical complications of substance abuse, human immunodeficiency virus (HIV), hepatitis C virus (HCV)
Mi Informacion de Contacto
Ubicación Primaria725 Albany Street
Boston, MA 02118
Más sobre mí
Título AdministrativoLouis W. Sullivan, MD, Professor of Medicine and Assistant Professor, Boston University Chobanian & Avedisian School of Medicine
ResidenciaInternal Medicine/Pediatrics, Brown University/Rhode Island Hospital-Lifespan
BecasInfectious Disease, Beth Israel Deaconess Medical Center
Certificaciones de la JuntaInternal Medicine and Infectious Disease, American Board of Internal Medicine
Intereses EspecialesMedical complications of substance abuse, human immunodeficiency virus (HIV), hepatitis C virus (HCV)
Boston University es una institución de investigación privada líder con dos campus principales en el corazón de Boston y programas en todo el mundo.
Como principal afiliado de enseñanza de la Escuela de Medicina Chobanian & Avedisian de la Universidad de Boston, Boston Medical Center se dedica a capacitar a las futuras generaciones de profesionales de la salud. Obtenga más información sobre la Facultad de Medicina de la Universidad de Boston.
Ver mi perfil de Boston University Facultad de Medicina Chobanian & Avedisian
Presentado en HealthCity
'Community Leaders Have More Impact on Neighbors Than Celebrities' In COVID-19 Vaccine Trust
Boston Medical Center learned crucial lessons about public health messaging during community conversations about the COVID-19 vaccine and pandemic.
Making the Case for Employer-Sponsored Addiction Treatment
In a hypothetical firm of 10,000 employees, researchers estimated $232,000 of lost wage value annually due to SUD-related absenteeism.
What Role Can Medical Centers Play in the Equitable Rollout of COVID-19 Vaccines?
BMC model may serve as a blueprint for other medical centers committed to increasing access to vaccines through community-based interventions.
BMC Joins a New NIH Alliance to Address COVID-19 Inequities
By hearing stories of people in underserved neighborhoods, researchers hope to understand and help overcome longstanding barriers to healthcare access
We Must Fortify Primary Care to Treat Long COVID
About 10-30% of COVID-19 patients feel effects months later. Effectively treating long-term COVID symptoms means reimaging healthcare systems.
How to Talk With Patients Who've Had COVID-19 About the Vaccine
In a webinar hosted by the Roxbury Presbyterian Church, epidemiologist Cassandra Pierre, MD, MPH, addressed a common COVID-19 vaccine question.
HCV Treatment Uptake Hinges on Learning Directly from Patients
ID physicians engaged patients with hepatitis C and substance use disorder on how to best integrate comprehensive treatment into their lives.
Fighting Vaccine Hesitancy in Groups Hardest Hit by COVID-19
Transparency and culturally appropriate communication are key to counteracting the hesitancy that could diminish the impact of a COVID-19 vaccine.
COVID-19 and Racism: Changing Predictable Outcomes
Experts raise concerns for post-pandemic repercussions and call for prioritization of the social determinants within medicine.
A Gap in Diagnosis of Hep C Infections During the Opioid Epidemic
A new analysis shows that federally qualified health centers, which serve higher rates of people with HCV, largely aren't testing for the virus.
Study: Improvements Needed for Hepatitis C Testing in Youth
Young people represent an increasing proportion of all HCV cases, but rates of testing and treatment for this group are poor, research finds.